Cardinal Health (NYSE: CAH) reported Q3 EPS of $1.62, $0.19 better than the analyst estimate of $1.43. Revenue for the quarter came in at $39.2 billion versus the consensus estimate of $36.95 billion.

• Revenue increased 11% to $39.2 billion
• GAAP operating earnings increased 30% to $562 million, non-GAAP operating earnings increased 8% to $719 million
• GAAP diluted earnings per share (EPS) increased 20% to $1.19, while non-GAAP diluted EPS increased 2% to $1.62.
• Company reaffirms FY20 guidance

"I want to express my gratitude to our employees and our partners across the healthcare industry for their incredible efforts to help us perform our critical role in the supply chain during this unprecedented time," said Mike Kaufmann, CEO of Cardinal Health. "We remain committed to delivering products and solutions to front-line health care providers so they can safely serve and treat patients around the world. As we look toward and beyond the fourth quarter, we will continue to take strategic actions to fulfill this mission."

GUIDANCE:

Cardinal Health sees FY2020 EPS of $5.20-$5.40, versus the consensus of $5.19.

For earnings history and earnings-related data on Cardinal Health (CAH) click here.